International Journal of Radiation Oncology*Biology*Physics
Clinical investigationIntensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume
Introduction
Oropharyngeal carcinoma is usually squamous in origin. When tumor presents in advanced stages, the prognosis is poor (1). The management of primary oropharyngeal squamous cell carcinoma remains controversial. Surgery and postoperative radiotherapy (RT) is a commonly used strategy. Although this approach can yield satisfactory locoregional control, it may result in functional alteration and does not prevent distant metastasis. An alternative therapeutic modality, conventional RT, can also address the primary tumor site and the adjacent lymphatic drainage. However, conventional RT frequently impairs salivary gland function, causing permanent xerostomia. Recent technological advances have led to the successful clinical implementation of intensity-modulated RT (IMRT), an advanced form of three-dimensional RT. The initial results have been encouraging and suggest potential improvements in locoregional control rates and toxicity profiles 2, 3.
Patients with oropharyngeal carcinoma are ideally suited for IMRT, because this technique can conform to tumors with concave features, optimize tumor target coverage, and spare adjacent critical structures, most notably the salivary glands 4, 5, 6, 7. We previously showed that, compared with conventional RT, IMRT reduced late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma (5). The objectives of this paper were to update our therapeutic outcomes with IMRT for oropharyngeal carcinoma and to analyze the impact of tumor volume on locoregional control and disease-free survival.
Section snippets
Patients and tumor characteristics
Between February 1997 and December 2001, 74 oropharyngeal cancer patients (13 women and 61 men; median age, 55 years; range, 35–76 years) were treated with IMRT either definitively (n = 31; 42%) or postoperatively (n = 43; 58%). The primary site was the tonsil in 50, base of tongue in 18, and soft palate in 6 patients. The American Joint Committee on Cancer (AJCC) staging system was used according to the primary tumor location (8). The T stage was T1 in 16, T2 in 25, T3 in 14, and T4 in 19
Results
Ten locoregional failures were found. Six patients died of disease and three died of concurrent disease. Distant metastasis developed in 6 patients. The 4-year estimate of overall survival was 87%, and the 4-year estimate of disease-free survival (DFS) was 81%. The 4-year estimate of locoregional control was 87%, and the 4-year estimate of distant metastasis-free survival (DMFS) was 90% (84% in the definitive vs. 94% in the postoperative group; Fig. 1).
Univariate analysis, taking gender,
Discussion
In the past few years, many studies dealing with the planning, delivery, and quality assurance of IMRT have been published. However, outcomes analyses validating the potential benefits and drawbacks of this novel technology are sparse. Because of the complexity of implementing IMRT, only a few reports benchmarking the treatment outcome of head-and-neck cancers have been published 2, 13. Lee et al.(13) reported excellent therapeutic results in nasopharyngeal carcinoma treated with IMRT without
Conclusion
Our results showed that IMRT for oropharyngeal cancers is clinically feasible and results in satisfactory locoregional control and survival rates. The GTV is an important parameter to predict survival and locoregional control.
References (34)
- et al.
Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer
Int J Radiat Oncol Biol Phys
(2003) - et al.
Intensity modulated radiation therapy for oropharyngeal and oral cavity tumorsClinical use and experience
Oral Oncol
(2002) - et al.
Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinomaA comparison with conventional techniques
Radiother Oncol
(2001) - et al.
A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapyInitial results
Int J Radiat Oncol Biol Phys
(2001) - et al.
Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT
Int J Radiat Oncol Biol Phys
(2002) - et al.
Clinical experience of head-and-neck cancer IMRT with serial tomotherapy
Med Dosim
(2002) - et al.
Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
Int J Radiat Oncol Biol Phys
(1995) - et al.
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinomaAn update of the UCSF experience
Int J Radiat Oncol Biol Phys
(2002) - et al.
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinomaThree meta-analyses of updated individual data
Lancet
(2000) - et al.
Locoregionally advanced carcinoma of the oropharynxConventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy—A multicenter randomized trial
Int J Radiat Oncol Biol Phys
(2003)
Intensity-modulated radiation therapy for head and neck cancerEmphasis on the selection and delineation of the targets
Semin Radiat Oncol
Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer
Int J Radiat Oncol Biol Phys
Limited external beam and interstitial 192iridium irradiation in the treatment of carcinoma of the base of the tongueA ten year experience
Int J Radiat Oncol Biol Phys
Squamous cell carcinoma of the oropharynxSurgery, radiation therapy, or both
Cancer
Intensity-modulated radiation therapy in head and neck cancersThe Mallinckrodt experience
Int J Cancer
Protection of salivary function by intensity-modulated radiation therapy in patients with head and neck cancer
Semin Radiat Oncol
AJCC cancer staging manual
Cited by (219)
Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer
2023, International Journal of Radiation Oncology Biology PhysicsTumor volume definitions in head and neck squamous cell carcinoma – Comparing PET/MRI and histopathology
2023, Radiotherapy and OncologyHypoxia in relationship to tumor volume using hypoxia PET-imaging in head & neck cancer – A scoping review
2022, Clinical and Translational Radiation Oncology